Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mike Aicher
AddedMar 31, 2024
UpdatedMay 31, 2026
Mike Aicher

Mike Aicher

Board Member, Roswell Biotechnologies

CrunchbaseLinkedIn

Mike Aicher's Career

Roswell Biotechnologies
Roswell Biotechnologies
Board Member· Board
Alveo Technologies
Alveo Technologies

Alameda, CA, US

Co-Founder
Techcyte
Techcyte

Orem, UT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mike Aicher's Career

Roswell Biotechnologies
Roswell Biotechnologies
Series A$37M422014
Board Member· Board

Leadership at Roswell Biotechnologies

Barry MerrimanBarry MerrimanCo-Founder
Paul MolaPaul MolaCo-Founder

Similar to Roswell Biotechnologies

NorthShore BioNorthShore BioCamas, WA, USMolecular Detectionest. 2009NorthShore BioCamas, WA, US · est. 2009

NorthShore Bio: Innovating a silicon-chip Molecular Detection Platform technology.

Series A · $1.5M30
OnteraOnteraSanta Cruz, CA, USDnarna Analysisest. 2011OnteraSanta Cruz, CA, US · est. 2011

Advanced DNA/RNA examination platform using silicon nanopore chips for precise molecule detection.

Seed · $32.6M175
NanopathNanopathCambridge, MA, USDiagnostics, Womens Healthest. 2019NanopathCambridge, MA, US · est. 2019

Nanopath: A molecular diagnostics firm revolutionizing testing for women's health in a single visit.

Series A · $10.3M30
Electronic BiosciencesElectronic BiosciencesSan Diego, CA, USDNA Sequencingest. 2002Electronic BiosciencesSan Diego, CA, US · est. 2002

San Diego-based Electronic Biosciences develops sensitive systems for DNA sequencing and chemical sensing.

Angel · $481k11
Alveo Technologies
Alveo Technologies
Series A$54M632014Alameda, CA, US
Co-Founder

Leadership at Alveo Technologies

Lawrence BlattLawrence BlattCo-Founder
Shaun HoltShaun HoltBoard Member
Michael MarksMichael MarksBoard Member
Neil GunnNeil GunnBoard Member
Ron ChiarelloRon ChiarelloCo-Founder
Robin SteeleRobin SteeleBoard Member
Techcyte
Techcyte
Series A$35.4M1152013Orem, UT, US
Board Member· Board

Leadership at Techcyte

Troy BankheadTroy BankheadCo-Founder
Rick SmithRick SmithBoard Member
Ralph YarroRalph YarroBoard Member
Ben CahoonBen CahoonCEO

Mike Aicher's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Mike Aicher

Raj KrishnanRaj KrishnanCo-Founder · Biological DynamicsMicah PearlmanMicah PearlmanCo-Founder · Aulos BioscienceIrwin JacobsIrwin JacobsCo-Founder · QualcommAnthony ShuberAnthony ShuberFounder · Exact SciencesPaul BillingsPaul BillingsCEO · Biological DynamicsMike GiardelloMike GiardelloCo-Founder · Mount Wilson Ventures